Cargando…
Development of a novel hyaluronic acid membrane for the treatment of ocular surface diseases
Ocular surface diseases (OSD) can cause serious visual deterioration and discomfort. Commercial artificial tear solution containing hyaluronic acid (HA) show excellent biocompatibility and unique viscoelastic characteristics. Here, we developed a novel HA membrane (HAM) by chemical crosslinking usin...
Autores principales: | Kim, Dong Ju, Jung, Mi-Young, Pak, Ha-Jin, Park, Joo-Hee, Kim, Martha, Chuck, Roy S., Park, Choul Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840674/ https://www.ncbi.nlm.nih.gov/pubmed/33504908 http://dx.doi.org/10.1038/s41598-021-81983-1 |
Ejemplares similares
-
Moxifloxacin releasing intraocular implant based on a cross-linked hyaluronic acid membrane
por: Kim, Dong Ju, et al.
Publicado: (2021) -
Evaluation of moxifloxacin-induced cytotoxicity on human corneal endothelial cells
por: Park, Joo-Hee, et al.
Publicado: (2021) -
The role of macrophage migration inhibitory factor in ocular surface disease pathogenesis after chemical burn in the murine eye
por: Oh, Sei Yeul, et al.
Publicado: (2010) -
Effect of Nitric Oxide on Human Corneal Epithelial Cell Viability and Corneal Wound Healing
por: Park, Joo-Hee, et al.
Publicado: (2017) -
Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model
por: Zhu, Lei, et al.
Publicado: (2009)